Stay updated on CPX-351 and Ivosidenib in IDH1 AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.
Latest updates to the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page
- ChecktodayChange DetectedA new addition was made on October 15, 2024, while there were deletions noted on September 19, 2024.SummaryDifference0.7%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
- Check22 days agoChange DetectedThe website has been updated to version v2.11.0, while a previous notice regarding delays in displaying study record information has been removed.SummaryDifference4%
- Check30 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check44 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.3%
- Check65 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
Stay in the know with updates to CPX-351 and Ivosidenib in IDH1 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.